ProfileGDS4718 / 215736_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 9% 14% 7% 11% 11% 19% 7% 17% 13% 14% 14% 18% 16% 15% 15% 11% 15% 12% 14% 13% 16% 9% 15% 17% 4% 14% 11% 7% 18% 15% 17% 12% 13% 13% 12% 10% 8% 14% 9% 12% 19% 14% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.7831610
GSM549102patient 115, normal, homogenized [OPG study]3.76949
GSM549104patient 119, normal, homogenized [OPG study]3.9087114
GSM549108patient 138, normal, homogenized [OPG study]3.669337
GSM549119patient 077, normal, homogenized [OPG study]3.8353911
GSM549133patient 032, cancer, homogenized [OPG study]3.7713811
GSM549139patient 042, cancer, homogenized [OPG study]4.0809119
GSM549099patient 107, normal, homogenized [OPG study]3.67887
GSM549109patient 139, normal, homogenized [OPG study]4.0599317
GSM549110patient 046, normal, homogenized [OPG study]3.8993313
GSM549114patient 063, normal, homogenized [OPG study]3.9158714
GSM549122patient 082, normal, homogenized [OPG study]3.9202314
GSM549134patient 033, cancer, homogenized [OPG study]4.0553318
GSM549136patient 036, cancer, homogenized [OPG study]3.9400216
GSM549140patient 044, cancer, homogenized [OPG study]3.9387815
GSM549111patient 047, normal, homogenized [OPG study]3.9305715
GSM549113patient 057, normal, homogenized [OPG study]3.7973711
GSM549132patient 031, cancer, homogenized [OPG study]3.9508915
GSM549137patient 038, cancer, homogenized [OPG study]3.8512112
GSM549142patient 047, cancer, homogenized [OPG study]3.9787314
GSM549100patient 110, normal, homogenized [OPG study]3.9060713
GSM549107patient 135, normal, homogenized [OPG study]3.9617116
GSM549115patient 068, normal, homogenized [OPG study]3.720589
GSM549116patient 072, normal, homogenized [OPG study]3.9372315
GSM549120patient 078, normal, homogenized [OPG study]4.0379717
GSM549131patient 030, cancer, homogenized [OPG study]3.529054
GSM549118patient 074, normal, homogenized [OPG study]3.9329614
GSM549129patient 027, cancer, homogenized [OPG study]3.8440311
GSM549123patient 088, normal, homogenized [OPG study]3.67167
GSM549124patient 006, cancer, homogenized [OPG study]4.1169418
GSM549126patient 015, cancer, homogenized [OPG study]3.9423315
GSM549128patient 025, cancer, homogenized [OPG study]3.9972517
GSM549103patient 117, normal, homogenized [OPG study]3.8685612
GSM549117patient 073, normal, homogenized [OPG study]3.8913
GSM549138patient 041, cancer, homogenized [OPG study]3.8552313
GSM549141patient 045, cancer, homogenized [OPG study]3.8081712
GSM549130patient 028, cancer, homogenized [OPG study]3.8010910
GSM549101patient 111, normal, homogenized [OPG study]3.710528
GSM549105patient 128, normal, homogenized [OPG study]3.9402314
GSM549106patient 134, normal, homogenized [OPG study]3.707319
GSM549112patient 048, normal, homogenized [OPG study]3.8525912
GSM549125patient 011, cancer, homogenized [OPG study]4.1212619
GSM549127patient 024, cancer, homogenized [OPG study]3.9111414
GSM549135patient 035, cancer, homogenized [OPG study]3.8656614